Yujie Zhao, MD, PhD

PrintE-mail
Assistant Professor of Oncology
Roswell Park Cancer Institute

Profile

Areas of Expertise: 
Head and Neck
Medical Oncology

Research

Research Interests: 
Phase I clinical trials
Novel therapeutics for head and neck cancer

Background Information

Education and Training: 
MD - Beijing Medical University (Center of Health Science, Peking University), Beijing, China (1994)
PhD – Rutgers University/University of Medicine and Dentistry of New Jersey, Piscataway, NJ (2004)
Residency: 
Saint Barnabas Medical Center, New Jersey Medical School, Livingston, NJ
Board Certification: 
American Board of Internal Medicine
Fellowships: 
Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ

Publications

Publications: 
  • Zhao Y, Gounder M, Lin H, Addo KH, Levinson KT, LaRosiliere M, Goodin S, Moss RA, Tan AR, Stein MN. Phase I study of at-101 (R-(-)-gossypol) in combination with paclitaxel (P) and carboplatin (C) in solid tumors including castrate-resistant prostate cancer (CRPC) : 2011 Genitourinary Cancers Symposium. Journal of clinical oncology 2011; 29(7 Suppl.):169
  • Zhao Y. Vandetanib in the management of thyroid cancer. International journal of targeted therapies in cancer 2012; September:44-48